511.35MMarket Cap-0.44P/E (TTM)
23.930High17.720Low197.66KVolume23.640Open23.790Pre Close3.90MTurnover2.26%Turnover RatioLossP/E (Static)25.41MShares41.87052wk High670.67P/B176.04MFloat Cap11.66552wk Low--Dividend TTM8.75MShs Float728.003Historical High--Div YieldTTM26.10%Amplitude11.665Historical Low19.753Avg Price1Lot Size
Cartesian Therapeutics Stock Forum
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment
Dow Jones· just
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.1%), etc.
SEC announcement
13 mins ago
Cartesian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals...
No comment yet